A detailed history of Balyasny Asset Management LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 179,940 shares of ALT stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
179,940
Holding current value
$1.4 Million
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.5 - $8.1 $989,670 - $1.46 Million
179,940 New
179,940 $1.1 Million
Q3 2023

Nov 14, 2023

BUY
$2.4 - $3.45 $595,322 - $855,775
248,051 Added 35.46%
947,578 $2.46 Million
Q2 2023

Aug 14, 2023

BUY
$3.45 - $5.97 $720,494 - $1.25 Million
208,839 Added 42.56%
699,527 $2.47 Million
Q1 2023

May 15, 2023

BUY
$4.19 - $16.83 $1.3 Million - $5.23 Million
310,940 Added 172.99%
490,688 $2.07 Million
Q4 2022

Feb 14, 2023

SELL
$8.74 - $16.45 $7.5 Million - $14.1 Million
-857,914 Reduced 82.68%
179,748 $2.96 Million
Q3 2022

Nov 14, 2022

BUY
$10.67 - $22.41 $8.87 Million - $18.6 Million
831,193 Added 402.58%
1,037,662 $13.3 Million
Q2 2022

Aug 15, 2022

BUY
$3.94 - $11.77 $813,487 - $2.43 Million
206,469 New
206,469 $2.42 Million

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $380M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.